19.49 USD
+0.59 (+3.12%)
19.2 USD
-0.29 (-1.49%)
NRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are quite some concerns on its financial health. NRC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
NRC had positive earnings in the past year.
In the past year NRC had a positive cash flow from operations.
Each year in the past 5 years NRC has been profitable.
In the past 5 years NRC always reported a positive cash flow from operatings.
1.2 Ratios
NRC has a better Return On Assets (12.03%) than 97.03% of its industry peers.
With an excellent Return On Equity value of 116.86%, NRC belongs to the best of the industry, outperforming 99.01% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 21.81%, NRC belongs to the top of the industry, outperforming 96.04% of the companies in the same industry.
NRC had an Average Return On Invested Capital over the past 3 years of 37.14%. This is significantly above the industry average of 9.21%.
The 3 year average ROIC (37.14%) for NRC is well above the current ROIC(21.81%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.03% | ||
| ROE | 116.86% | ||
| ROIC | 21.81% |
ROA(3y)22.86%
ROA(5y)24.04%
ROE(3y)62.69%
ROE(5y)57.96%
ROIC(3y)37.14%
ROIC(5y)35.28%
1.3 Margins
Looking at the Profit Margin, with a value of 11.76%, NRC belongs to the top of the industry, outperforming 98.02% of the companies in the same industry.
NRC's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 19.81%, NRC belongs to the top of the industry, outperforming 97.03% of the companies in the same industry.
NRC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 62.05%, NRC belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
NRC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.81% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% |
OM growth 3Y-10.34%
OM growth 5Y-6.05%
PM growth 3Y-11.57%
PM growth 5Y-7.08%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NRC is creating value.
Compared to 1 year ago, NRC has less shares outstanding
Compared to 5 years ago, NRC has less shares outstanding
NRC has a worse debt/assets ratio than last year.
2.2 Solvency
NRC has an Altman-Z score of 3.56. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
NRC's Altman-Z score of 3.56 is fine compared to the rest of the industry. NRC outperforms 73.27% of its industry peers.
NRC has a debt to FCF ratio of 6.45. This is a slightly negative value and a sign of low solvency as NRC would need 6.45 years to pay back of all of its debts.
NRC has a Debt to FCF ratio (6.45) which is in line with its industry peers.
A Debt/Equity ratio of 5.43 is on the high side and indicates that NRC has dependencies on debt financing.
The Debt to Equity ratio of NRC (5.43) is worse than 79.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.43 | ||
| Debt/FCF | 6.45 | ||
| Altman-Z | 3.56 |
ROIC/WACC2.47
WACC8.82%
2.3 Liquidity
A Current Ratio of 0.51 indicates that NRC may have some problems paying its short term obligations.
NRC has a Current ratio of 0.51. This is amonst the worse of the industry: NRC underperforms 86.14% of its industry peers.
NRC has a Quick Ratio of 0.51. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
NRC has a worse Quick ratio (0.51) than 85.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 |
3. Growth
3.1 Past
NRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.95%.
NRC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.77% yearly.
NRC shows a decrease in Revenue. In the last year, the revenue decreased by -3.50%.
Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 2.25% on average per year.
EPS 1Y (TTM)-35.95%
EPS 3Y-10.69%
EPS 5Y-3.77%
EPS Q2Q%-20.83%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.07, NRC can be considered very expensive at the moment.
NRC's Price/Earnings ratio is a bit cheaper when compared to the industry. NRC is cheaper than 60.40% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.00, NRC is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.07 | ||
| Fwd PE | N/A |
4.2 Price Multiples
NRC's Enterprise Value to EBITDA ratio is in line with the industry average.
NRC's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.59 | ||
| EV/EBITDA | 15.04 |
4.3 Compensation for Growth
NRC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.41%, NRC has a reasonable but not impressive dividend return.
NRC's Dividend Yield is rather good when compared to the industry average which is at 0.60. NRC pays more dividend than 98.02% of the companies in the same industry.
NRC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
5.2 History
The dividend of NRC decreases each year by -17.96%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NRC pays out 65.04% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of NRC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP65.04%
EPS Next 2YN/A
EPS Next 3YN/A
19.49
+0.59 (+3.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners49.6%
Inst Owner Change0%
Ins Owners10.45%
Ins Owner Change2.62%
Market Cap441.64M
Revenue(TTM)139.10M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.58%
Short Ratio4.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.41% |
Yearly Dividend0.47
Dividend Growth(5Y)-17.96%
DP65.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.07 | ||
| Fwd PE | N/A | ||
| P/S | 3.17 | ||
| P/FCF | 35.59 | ||
| P/OCF | 16.99 | ||
| P/B | 29.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.04 |
EPS(TTM)0.72
EY3.69%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.55
FCFY2.81%
OCF(TTM)1.15
OCFY5.89%
SpS6.14
BVpS0.66
TBVpS-2.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.03% | ||
| ROE | 116.86% | ||
| ROCE | 28.4% | ||
| ROIC | 21.81% | ||
| ROICexc | 22.32% | ||
| ROICexgc | 79.94% | ||
| OM | 19.81% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% | ||
| FCFM | 8.92% |
ROA(3y)22.86%
ROA(5y)24.04%
ROE(3y)62.69%
ROE(5y)57.96%
ROIC(3y)37.14%
ROIC(5y)35.28%
ROICexc(3y)44.1%
ROICexc(5y)48.5%
ROICexgc(3y)275.8%
ROICexgc(5y)N/A
ROCE(3y)48.38%
ROCE(5y)45.95%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-22.2%
ROICexc growth 5Y-12.25%
OM growth 3Y-10.34%
OM growth 5Y-6.05%
PM growth 3Y-11.57%
PM growth 5Y-7.08%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.43 | ||
| Debt/FCF | 6.45 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 194.42% | ||
| Cap/Sales | 9.77% | ||
| Interest Coverage | 7.14 | ||
| Cash Conversion | 75.28% | ||
| Profit Quality | 75.86% | ||
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 | ||
| Altman-Z | 3.56 |
F-Score6
WACC8.82%
ROIC/WACC2.47
Cap/Depr(3y)235.57%
Cap/Depr(5y)169.24%
Cap/Sales(3y)9.25%
Cap/Sales(5y)6.89%
Profit Quality(3y)78.03%
Profit Quality(5y)88.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.95%
EPS 3Y-10.69%
EPS 5Y-3.77%
EPS Q2Q%-20.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.07%
EBIT growth 3Y-11.35%
EBIT growth 5Y-3.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.58%
FCF growth 3Y-21.17%
FCF growth 5Y-11.22%
OCF growth 1Y-24.68%
OCF growth 3Y-8.93%
OCF growth 5Y-3.08%
NATIONAL RESEARCH CORP / NRC FAQ
What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
Can you provide the valuation status for NATIONAL RESEARCH CORP?
ChartMill assigns a valuation rating of 2 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.
What is the profitability of NRC stock?
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?
The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 27.07 and the Price/Book (PB) ratio is 29.44.
Can you provide the financial health for NRC stock?
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.